Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chapman, Sherita N, Mehndiratta, Prachi, Johansen, Michelle C, McMurry, Timothy L, Johnston, Karen C, Southerland, Andrew M
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://ncbi.nlm.nih.gov/pubmed/24591838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados